InflaRx Receives Positive CHMP Opinion for GOHIBIC® (Vilobelimab) for the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome Written by Kirsten Ruehl on 15th November 2024. Posted in Client News. Previous Next
